• OPEN AN ACCOUNT
Indian Indices
Nifty
15,752.05 -28.20
(-0.18%)
Sensex
52,907.93 -111.01
( -0.21%)
Bank Nifty
33,539.45 114.35
( 0.34%)
Nifty IT
28,064.25 220.90
( 0.79%)
Global Indices
Nasdaq
11,028.74 -149.15
(-1.33%)
Dow Jones
30,775.43 -253.88
(-0.82%)
Hang Seng
21,859.79 -137.10
(-0.62%)
Nikkei 225
25,935.62 -457.42
(-1.73%)
Forex
USD-INR
78.74 0.11
(0.14%)
EUR-INR
82.59 -0.39
(-0.47%)
GBP-INR
95.74 -0.44
(-0.46%)
JPY-INR
0.58 0.00
(-0.22%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01023
1101.6634479
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
44.96
72973.66
EPS(TTM)
Face Value()
Div & Yield %
97.52
5
0.68
 

Rubber Products Ltd
Rubber Products Ltd - Results_Financial Results For Quarter June 2021
Aug 12,2021
Pursuant to Regulation 33 (3) of the SEBI (LODR) Regulations 2015 read with Regulation 30 of SEBI (LODR) Regulations 2015 it is hereby informed that the Board of Directors today i.e. 12th August 2021 at their meeting transacted and approved the following business amongst others. The Un-audited (Standalone) Financial Results of the Company for the quarter ended June 30 2021 along with the Limited Review Report; a copy of same is enclosed herewith as Annexure. Meeting Commenced at 8:45 p.m. and concluded at 9:15 p.m.